Noom Med vs Remedy Meds (2026): prices, structure, verdict

On tirzepatide, only Remedy Meds↗ has a rankable figure: $399 a month all-in; Noom Med↗ does not offer tirzepatide.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

On semaglutide, Noom Med is cheaper: $199 versus $299 a month all-in — a $100 monthly gap, $1,200 across a year of maintenance dosing.

§ Side by side

§ Each record, read aloud

The two records, condensed

Noom Med: the record, condensed

On semaglutide, the number that matters at Noom Med is $199 a month all-in — the figure at the 2.4 mg maintenance basis this whole site ranks on. The price is dose-flat: the standard titration ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg) is financially invisible here, because the top rung bills exactly what the bottom rung billed. That converts the advertised number from a floor into a ceiling — the strongest single structural feature a program in this category can have.

There is no membership line. $199 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #12 of 20 in the verified semaglutide index — $66/month above the floor (Oak Longevity, $133) — and sits $150 under the brand benchmark (Wegovy (NovoCare↗), $349 at maintenance). Annualized, a monthly-billed year here runs $2,388.

Operationally at Noom Med: shipping included; commitment 12-week cycles; cancellation 12-week billing cycles; pharmacy named (Tailor Made Compounding (named)); states: most states; evidence source-verified, captured 2026-08-08. The full record with source and archive links: the Noom Med page · visit Noom Med ↗

Remedy Meds: the record, condensed

On tirzepatide, the number that matters at Remedy Meds is $399 a month all-in — the figure at the 10 mg maintenance basis this whole site ranks on. It is a flat structure: 2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available) all bill identically. In a market where most low advertised prices quietly belong to the starter dose, a flat figure is the difference between a quote and a teaser.

The absence worth noticing: no mandatory membership. Across this index memberships run $25–$145 a month and hide outside headline prices; here the headline is the bill.

To place the number: #15 of 17 verified programs, with the floor $184/month below at NexLife↗ ($215); the approved-product yardstick (Zepbound (LillyDirect↗)) sits at $449, so the compounded case here is worth $50 a month. A year at this figure: $4,788 monthly-billed.

Remedy Meds’s semaglutide program bills $299 a month once every mandatory fee is counted, measured at the 2.4 mg maintenance basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at Remedy Meds is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.

There is no membership line. $299 is the billed total — consultation and clinical review are inside it, and no platform fee recurs beside it, which removes the most common way advertised GLP-1 prices understate billed ones.

Context for that figure: it ranks #19 of 20 in the verified semaglutide index — $166/month above the floor (Oak Longevity, $133) — and sits $50 under the brand benchmark (Wegovy (NovoCare), $349 at maintenance). Annualized, a monthly-billed year here runs $3,588.

Operationally at Remedy Meds: shipping included; commitment unknown; cancellation not published; pharmacy not publicly named — ask in writing before paying; states: not published; evidence third-party reported, captured 2026-08-05. The full record with source and archive links: the Remedy Meds page · visit Remedy Meds ↗

Semaglutide: the duel in full

The semaglutide arithmetic between these two is short: $199 (Noom Med) against $299 (Remedy Meds). $100 a month sounds survivable; $1,200 a year is a decision.

Both figures are dose-flat, which is the cleanest possible comparison: two ceilings, no titration surprises on either side, and the $100 gap is exactly what it appears to be.

A way to feel the $100 monthly gap: over a year it funds 6.0 extra months at Noom Med’s own rate — the difference is not decoration, it is medication. Over two years it compounds to $2,400, which is the horizon at which structural details (prepaid ladders, membership drag, dose-tier repricing) start mattering more than the sticker itself.

Run the same two programs on the committed basis: Noom Med $199/mo month-to-month against Remedy Meds $299/mo month-to-month. The order holds: Noom Med leads on both readings, so plan structure sharpens the verdict here rather than reversing it. Whichever basis fits your commitment level, the upfront totals above are the honest units.

§ The clock, run forward

Three, six, twelve, twenty-four months — best path each way

3 months: Noom Med $597 monthly; Remedy Meds $897 monthly — best path favors Noom Med by $300. 6 months: Noom Med $1,194 monthly; Remedy Meds $1,794 monthly — best path favors Noom Med by $600. 12 months: Noom Med $2,388 monthly; Remedy Meds $3,588 monthly — best path favors Noom Med by $1,200. 24 months: Noom Med $4,776 monthly; Remedy Meds $7,176 monthly — best path favors Noom Med by $2,400.

Prepaid paths above are billed upfront and assume the published rate holds (the 24-month figures extend the 12-month rate, an assumption worth naming). The honest reading: over short horizons the monthly gap decides; over long horizons the prepaid ladders and structural traps (dose tiers, memberships) take over — which is exactly the split the verdict section below scores.

§ Structure vs structure

Everything besides the price

Coverage: Noom Med publishes “most states”; Remedy Meds publishes “not published” — for anything short of an explicit 50-state claim, intake is the final word.

Pharmacy transparency splits them: Noom Med names its network (Tailor Made Compounding (named)); Remedy Meds does not, which shifts the burden of verification onto your intake questions.

Exit terms: Noom Med — 12-week cycles; 12-week billing cycles. Remedy Meds — unknown; not published.

Evidence: Noom Med source-verified (captured 2026-08-08); Remedy Meds third-party reported (2026-08-05).

The pattern worth internalizing: in this market, structural honesty and price honesty travel together. Programs that publish pharmacies and state lists tend to publish real maintenance prices; programs that hide one usually hide the other.

In the full semaglutide index these two sit at #12 and #19 of 20: between them lie 6 other programs, and the whole ladder is at cheapest semaglutide providers.

§ If you move

Switching between Noom Med and Remedy Meds

Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Noom Med: 12-week billing cycles; Remedy Meds: not published) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.

§ Verdict by situation

Which one, for whom

§ More pairings